Novel Antibody-Drug Conjugate Demonstrates Promising Efficacy in EGFR-Mutated NSCLC Patients
In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on ...
In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on ...
In an exciting development in the realm of cancer therapeutics, researchers have unveiled a novel antibody-drug conjugate (ADC) known as ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine